Related references
Note: Only part of the references are listed.Levodopa-induced dyskinesias in Parkinson's disease: Etiology, impact on quality of life, and treatments
Elmyra V. Encarnacion et al.
EUROPEAN NEUROLOGY (2008)
Molecular mechanisms underlying levodopa-induced dyskinesia
Paolo Calabresi et al.
MOVEMENT DISORDERS (2008)
Levodopa-induced dyskinesias
Giovanni Fabbrini et al.
MOVEMENT DISORDERS (2007)
Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias
Manuela Contin et al.
CLINICAL NEUROPHARMACOLOGY (2007)
Medical management of levodopa-associated motor complications in patients with Parkinson's disease
Joseph Jankovic et al.
CNS DRUGS (2007)
Clinical correlates of levodopa-induced dopamine release in Parkinson disease - A PET study
N. Pavese et al.
NEUROLOGY (2006)
Levetiracetam in tardive dyskinesia: An open label study
Spiros Konitsiotis et al.
MOVEMENT DISORDERS (2006)
Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesia
KE Lyons et al.
CLINICAL NEUROPHARMACOLOGY (2006)
Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs:: a prospective European study
M Péchevis et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease
TA Zesiewicz et al.
MOVEMENT DISORDERS (2005)
The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease
B Tousi et al.
PARKINSONISM & RELATED DISORDERS (2005)
Reciprocal interactions between oscillatory activities of different frequencies in the subthalamic region of patients with Parkinson's disease
N Fogelson et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Novel pharmacological strategies for motor complications in Parkinson's disease
S Konitsiotis
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Levetiracetam in L-dopa-induced dyskinesia
G Meco et al.
CLINICAL NEUROPHARMACOLOGY (2005)
Presynaptic mechanisms of motor fluctuations in Parkinson's disease:: a probabilistic model
R de la Fuente-Fernández et al.
BRAIN (2004)
Clozapine improves dyskinesias in Parkinson disease - A double-blind, placebo-controlled study
F Durif et al.
NEUROLOGY (2004)
Levedracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque
E Bezard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Parkinson's disease home diary: Further validation and implications for clinical trials
RA Hauser et al.
MOVEMENT DISORDERS (2004)
Levetiracetam interferes with the L-dopa priming process in MPTP-lesioned drug-naive marmosets
MP Hill et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset
MP Hill et al.
MOVEMENT DISORDERS (2003)
Switching and combining dopamine agonists
H Reichmann et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
How common are complications of Parkinson's disease?
A Schrag et al.
JOURNAL OF NEUROLOGY (2002)
Share Paper
